Navigation Links
Sonus Pharmaceuticals and OncoGenex Technologies to Merge
Date:5/28/2008

e asked to call the above numbers approximately 5-10 minutes prior to the start time. Additionally, the call will be broadcast live and can be accessed on the Sonus web site at http://ir.sonuspharma.com/events.cfm. A telephone replay of the call will be available from May 28, 2:00 p.m. Pacific Time, for three business days at 800-405-2236 or 303-590-3000 for international calls; Conference ID: 11114594 followed by the number sign.

Additional Information

As previously announced on November 5, 2007, Sonus received notification from the staff of The NASDAQ Stock Market indicating that the company is not in compliance with the $1.00 minimum bid price requirement for continued listing under Marketplace Rule 4450(a)(5). Sonus announced on May 8, 2008, that it had received a Determination Letter from NASDAQ indicating that the company had failed to regain compliance and is therefore to be delisted from The NASDAQ Global Market. Sonus has requested a hearing before a NASDAQ Listing Qualifications Panel to appeal NASDAQ's determination and intends to seek continued listing of its common stock. As part of its plan of compliance, Sonus also intends to effect a reverse stock split, subject to stockholder approval. Subject to NASDAQ's determination, Sonus intends to submit an application to change the ticker symbol to "OGXI" following consummation of the merger.

About Sonus Pharmaceuticals, Inc.

Headquartered near Seattle, Washington, Sonus Pharmaceuticals, Inc. is focused on the development of cancer drugs that are designed to provide better efficacy, safety and tolerability, and ease of use. Sonus moved an oncology product candidate, SN2310, into a Phase 1 clinical trial in September 2006. For additional information on Sonus, including past news releases, please visit http://www.sonuspharma.com.

About OncoGenex Technologies
'/>"/>

SOURCE OncoGenex Technologies Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. American Stock Exchange Lists the Common Stock of Rexahn Pharmaceuticals, Inc.
2. AMAG Pharmaceuticals, Inc. and 3SBio, Inc. Announce Strategic Partnership to Develop and Commercialize Ferumoxytol in China
3. Amylin Pharmaceuticals to Present at Annual Meeting of Stockholders
4. Amylin Pharmaceuticals to Present at FBR Capital Markets Investor Conference
5. VentiRx Pharmaceuticals Appoints Dr. Elliott Grossbard to Board of Directors
6. West Pharmaceutical Services to Present at the 2008 UBS Global Specialty & Generic Pharmaceuticals Conference
7. Takeda Pharmaceuticals Establishes $3 Million Endowment with AGA Foundation
8. MAP Pharmaceuticals to Present at the 2008 Citi Investment Research Global Healthcare Conference
9. Indevus Pharmaceuticals Scheduled to Present at Upcoming Investor Conferences
10. Transdel Pharmaceuticals Closes $4 Million Financing
11. XTL Biopharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... FL (PRWEB) May 16, 2013 ... named Barbara A. Myers, CAE, to the newly ... In her new role, Myers will be responsible ... development and production strategies, advancing the Society’s Member-led ... processes and continuing to refine organizational, membership and ...
(Date:5/16/2013)... Ill. (PRWEB) May 16, 2013 ... and portable models, from Cole-Parmer is designed to ... enhanced line includes: , The new Cole-Parmer® ... true workhorses in the lab. They ensure a ... and plasma specimen separation. Their standard four-place swinging ...
(Date:5/16/2013)... , May 16, 2013  HealthSparq, a trusted ... the nation,s largest regional health plans, will debut ... Insurance Plans (AHIP) Institute 2013 conference on June ... results showing how health insurance companies across the ... consumer and marketplace demands for increased healthcare transparency. ...
(Date:5/16/2013)... As the weather warms, women everywhere are waiting for ... most make a statement with fashion, many change their makeup ... weather mixes makeup and sweat to produce, and increase acne ... during warmer months, Adult Acne treatment , Probiotic Action ... ways to deter breakouts. , Recently, an article from ...
Breaking Biology Technology:ISPE Names Barbara A. Myers, CAE, as Vice President of Professional Development 2Cole-Parmer Offers Enhanced Selection of Centrifuges 2HealthSparq to Reveal New Healthcare Transparency Benchmark Study at AHIP Institute 2013 2HealthSparq to Reveal New Healthcare Transparency Benchmark Study at AHIP Institute 2013 3Adult Acne Treatment, Probiotic Action Shares New Tips for Women on How to Fight Acne While Wearing Makeup 2
... Mass., Jan. 31 Inverness Medical,Innovations, Inc. (Amex: ... of rapid,diagnostic products for the consumer and professional ... 2008 Merrill Lynch Global,Pharmaceutical, Biotechnology and Medical Device ... the Grand Hotel Hyatt in New York City. ...
... PALO ALTO, Calif., Jan. 31 CV Therapeutics,Inc. (Nasdaq: ... an Investor Science,Day for the financial community in New ... a.m. EST., The event will be webcast live ... http://www.cvt.com ., About CV Therapeutics, CV Therapeutics, ...
... Jan. 31 Scientists from,deCODE genetics (Nasdaq: DCGN ... in the sequence of the human genome (SNPs) that,regulate ... the two,SNPs, located on chromosome 4p16, have a genome-wide ... the genome that occurs in the formation,of eggs and ...
Cached Biology Technology:Inverness Medical Innovations to Participate at 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 5, 2008 2CV Therapeutics to Host Investor Science Day on Thursday, February 7, 2008 2deCODE Discovers Gene Variants that May Help to Distribute the Work of Evolution between Men and Women 2deCODE Discovers Gene Variants that May Help to Distribute the Work of Evolution between Men and Women 3deCODE Discovers Gene Variants that May Help to Distribute the Work of Evolution between Men and Women 4
(Date:5/16/2013)... FASEB MARC (Maximizing Access to Research Careers) Program ... Society for Developmental Biology (SDB) 72nd Annual Meeting ... awards are meant to promote the entry of ... the mainstream of the basic science community and ... the SDB 2013 Annual Meeting. , Awards are ...
(Date:5/16/2013)... Northwestern University scientists have shown a gene involved in ... proper function of the circadian clock. , In ... found the gene, called Ataxin-2, keeps the clock responsible ... the gene, the rhythm of the fruit fly,s sleep-wake ... schedule difficult for the fly. , The discovery ...
(Date:5/16/2013)... 2013 The relationship between the heritable risk ... been clear. Schizophrenia is commonly associated with cognitive ... clues that reduced IQ may be linked to ... cognitive ability may precede the onset of schizophrenia ... healthy relatives of people diagnosed with schizophrenia. , ...
Breaking Biology News(10 mins):Gene involved in neurodegeneration keeps clock running 2Genetic risk for schizophrenia is connected to reduced IQ 2
... rich in natural antioxidants improves insulin sensitivity in insulin-resistant ... drug metformin, a preliminary study from Italy finds. The ... 92nd Annual Meeting in San Diego. "The beneficial ... for the first time one of their biological bases ...
... - A team of bioengineers from the University of ... computer neural network model to accurately predict how blood ... heart attack or stroke. Using an automated, robotic ... different combinations of biological stimuli like those experienced during ...
... five colleagues from other institutions have published in ... particularly in the Western Antarctic Peninsula, or WAP. ... toward South America. In their review paper, the co-authors, ... argue that research in this region is imperative because ...
Cached Biology News:Well-defined quantity of antioxidants in diet can improve insulin resistance 2Penn bioengineers create simulator to test blood platelets in virtual heart attacks 2Penn bioengineers create simulator to test blood platelets in virtual heart attacks 3Oceanographers call for more ocean observing in Antarctica 2
Immunogen: Synthetic peptide: M(1) C V P R S G L I L S(11) Storage: -20 C, Avoid Freeze/Thaw Cycles...
... pPIC3.5K vectors carry the kanamycin resistance gene ... Pichia. Spontaneous generation of multiple insertion events ... levels of Geneticin Reagent. Pichia transformants are ... their level of resistance to Geneticin Reagent. ...
...
Liquid. Phycoerythrin conjugate is in PBS, pH 7.4 containing 1% BSA and 0.1% sodium azide....
Biology Products: